7.30
前日終値:
$7.18
開ける:
$7.23
24時間の取引高:
5,031
Relative Volume:
0.16
時価総額:
$13.72M
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-6.29%
1か月 パフォーマンス:
-14.12%
6か月 パフォーマンス:
+42.02%
1年 パフォーマンス:
+0.00%
Neuphoria Therapeutics Inc Stock (NEUP) Company Profile
NEUP を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
NEUP
Neuphoria Therapeutics Inc
|
7.30 | 14.64M | 0 | 0 | 0 | 0.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
390.00 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
575.46 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
445.81 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
685.36 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
311.20 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Neuphoria Therapeutics Inc Stock (NEUP) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2023-09-28 | アップグレード | H.C. Wainwright | Neutral → Buy |
2023-09-28 | 繰り返されました | Maxim Group | Buy |
2022-01-10 | 開始されました | Berenberg | Buy |
2022-01-10 | 開始されました | Cantor Fitzgerald | Overweight |
2022-01-10 | 開始されました | Evercore ISI | Outperform |
2022-01-10 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Neuphoria Therapeutics Inc (NEUP) 最新ニュース
Volatility clustering patterns for Neuphoria Therapeutics Inc.Gap Down & Fast Moving Stock Watchlists - Newser
Sentiment analysis tools applied to Neuphoria Therapeutics Inc.July 2025 Volume & High Accuracy Swing Entry Alerts - Newser
Chart based exit strategy for Neuphoria Therapeutics Inc.Quarterly Portfolio Report & Long-Term Investment Growth Plans - Newser
Exit strategy if you’re trapped in Neuphoria Therapeutics Inc.July 2025 Breakouts & Capital Protection Trading Alerts - Newser
Is Neuphoria Therapeutics Inc. reversing from oversold territoryFed Meeting & Low Drawdown Trading Strategies - Newser
Is it too late to sell Neuphoria Therapeutics Inc.2025 Price Action Summary & Free Long-Term Investment Growth Plans - Newser
Is Neuphoria Therapeutics Inc. stock entering bullish territoryNew Guidance & Free Accurate Trade Setup Notifications - Newser
How to build a dashboard for Neuphoria Therapeutics Inc. stockPortfolio Gains Summary & Target Return Focused Stock Picks - Newser
Can momentum traders help lift Neuphoria Therapeutics Inc.Risk Management & Daily Profit Maximizing Tips - Newser
Statistical indicators supporting Neuphoria Therapeutics Inc.’s strengthJuly 2025 News Drivers & Intraday High Probability Setup Alerts - Newser
What to expect from Neuphoria Therapeutics Inc. in the next 30 daysPortfolio Growth Summary & Fast Gaining Stock Strategy Reports - Newser
Identifying reversal signals in Neuphoria Therapeutics Inc.2025 Stock Rankings & Free AI Powered Buy and Sell Recommendations - Newser
Will breakout in Neuphoria Therapeutics Inc. lead to full recoveryProfit Target & Free High Return Stock Watch Alerts - Newser
Neuphoria Therapeutics Inc. stock trend outlook and recovery path2025 Risk Factors & Consistent Profit Trading Strategies - Newser
Analyzing Neuphoria Therapeutics Inc. with multi timeframe charts2025 Major Catalysts & Technical Entry and Exit Tips - Newser
What momentum shifts mean for Neuphoria Therapeutics Inc.CPI Data & AI Powered Buy and Sell Recommendations - Newser
How hedge fund analytics apply to Neuphoria Therapeutics Inc. stock2025 Growth vs Value & Fast Exit and Entry Strategy Plans - Newser
Neuphoria Therapeutics Inc. stock momentum explained2025 Support & Resistance & Momentum Based Trading Signals - Newser
Forecasting Neuphoria Therapeutics Inc. price range with options dataPortfolio Risk Summary & Expert Curated Trade Setup Alerts - Newser
Evaluating Neuphoria Therapeutics Inc. with trendline analysisPortfolio Growth Summary & Weekly Sector Rotation Insights - Newser
Will Neuphoria Therapeutics Inc. continue its uptrend2025 Performance Recap & Real-Time Chart Breakout Alerts - Newser
How to integrate Neuphoria Therapeutics Inc. into portfolio analysis tools2025 Support & Resistance & High Yield Stock Recommendations - Newser
Published on: 2025-08-17 00:10:08 - Newser
Why Neuphoria Therapeutics Inc. stock attracts strong analyst attentionEarnings Recap Summary & Daily Entry Point Alerts - Newser
Analyzing drawdowns of Neuphoria Therapeutics Inc. with statistical toolsPortfolio Value Report & Free Accurate Trade Setup Notifications - Newser
Live market analysis of Neuphoria Therapeutics Inc.Chart Signals & Fast Exit and Entry Trade Guides - Newser
Is Neuphoria Therapeutics Inc.’s ROIC above industry averageJuly 2025 Review & Stepwise Entry/Exit Trade Alerts - 선데이타임즈
Combining machine learning predictions for Neuphoria Therapeutics Inc.July 2025 Setups & Low Risk Profit Maximizing Plans - Newser
What MACD and RSI say about Neuphoria Therapeutics Inc.Inflation Watch & Target Return Focused Picks - Newser
Neuphoria Therapeutics Inc (NEUP) 財務データ
Neuphoria Therapeutics Inc (NEUP) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):